Nucleoside and nucleotide reverse transcriptase inhibitors
Stavudine
The FDA lists this product in 19 strengths and forms.
Composition
- Active ingredients
- STAVUDINE 40MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- STAVUDINE 20MG · CapsuleANDA077672-004 · Discontinued
- STAVUDINE 40MG · CapsuleThis page
- STAVUDINE 15MG · CapsuleANDA077672-003 · Discontinued
- STAVUDINE 30MG · CapsuleANDA077672-001 · Discontinued
- STAVUDINE 1MG/ML · For solutionANDA078030-001 · Discontinued
- STAVUDINE 40MG · CapsuleANDA078587-001 · Tentative approval
- STAVUDINE 20MG · CapsuleANDA078957-002 · Discontinued
- STAVUDINE 30MG · CapsuleANDA078957-003 · Discontinued
- STAVUDINE 15MG · CapsuleANDA078957-001 · Discontinued
- STAVUDINE 40MG · CapsuleANDA078957-004 · Discontinued
- STAVUDINE 30MG · CapsuleANDA078256-001 · Tentative approval
- STAVUDINE 40MG · CapsuleANDA078256-002 · Tentative approval
- STAVUDINE 30MG · Capsule